Ortho Clinical Diagnostics Holdings plc
OCDXDelisted May 27, 2022- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001828443
Ortho Clinical Diagnostics Holdings plc was delisted on May 27, 2022; its insiders filed their last Form 4 on Jun 1, 2022; 170 institutions reported holding it in 13F filings for Q1 2022, worth $4.38B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ortho Clinical Diagnostics Holdings plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ortho Clinical Diagnostics Holdings plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bechtel Karen | Director | 0 | Jun 1, 2022 | 0 |
| Mac Mahon Thomas P | Director | 0Indirect | Jun 1, 2022 | 0 |
| Hull Carl | Director | 0Indirect | Jun 1, 2022 | 0 |
| Labrum Ronald K | Director | 0 | Jun 1, 2022 | 0 |
| Busky Joseph M | Chief Financial Officer | – | Jun 1, 2022 | 0 |
| Dilsaver Evelyn S | Director | 0 | Jun 1, 2022 | 0 |
| Smith Christopher M | Chairman and CEO | 0 | Jun 1, 2022 | 0 |
| Perez David Brian | Director | 0 | Jun 1, 2022 | 0 |
| Iskra Michael S. | Executive Vice President | 0 | Jun 1, 2022 | 0 |
| Schlesinger Michael A. | EVP, GC and Secretary | 0 | Jun 1, 2022 | 0 |
| Palaniappan Chockalingam | Chief Innovation Officer | – | Jun 1, 2022 | 0 |
| Yates Robert Clifton | Director | 0 | Jun 1, 2022 | 0 |
| TC Group Cayman Investment Holdings, L.P. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| Carlyle Group Inc. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| Carlyle Holdings II GP L.L.C. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| Carlyle Holdings II L.L.C. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| TC Group Cayman Investment Holdings Sub L.P. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| CG Subsidiary Holdings L.L.C. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| TC Group VI Cayman, L.L.C. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| Carlyle Partners VI Cayman Holdings, L.P. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
| TC Group VI Cayman, L.P. | 10% Owner | 0Indirect | May 31, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 (view filing) | Apr 4 | 2 days | Schlesinger Michael A.EVP, GC and Secretary | SSaleOrdinary Shares, $0.00001 par value | −88.0K | $18.77 | −$1.65M | −50.1%87.6K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Smith Christopher MChairman and CEO | SSaleOrdinary Shares, $0.00001 par value | −100.0K | $21.10 | −$2.11M | −21.4%367.4K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Schlesinger Michael A.EVP, GC and Secretary | SSaleOrdinary Shares, $0.00001 par value | −130.0K | $21.09 | −$2.74M | −59.7%87.6K after | |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Schlesinger Michael A.EVP, GC and Secretary | SSaleOrdinary Shares, $0.00001 par value | −75.5K | $19.73 | −$1.49M | −46.3%87.6K after | |
| Sep 16, 2021 (view filing)4:30 PM ET | Sep 14 | 2 days | TC Group Cayman Investment Holdings, L.P. and 8 others10% Owner | SSale | −25.3M | $16.80 | −$425.0M | −17.6%118.1M after | |
| Aug 18, 2021 (view filing) | Aug 16-18 | 2 days | Schlesinger Michael A.EVP, GC and Secretary | SSaleOrdinary Shares, $0.00001 par value | −45.0K | $20.13 | −$906.2K | −33.9%87.6K after | 2 lots |
| Aug 13, 2021 (view filing) | Aug 11-13 | 2 days | Schlesinger Michael A.EVP, GC and Secretary | SSaleOrdinary Shares, $0.00001 par value | −85.0K | $19.80 | −$1.68M | −49.2%87.6K after | 3 lots |
| Aug 4, 2021 (view filing) | Aug 2-4 | 2 days | Yates Robert CliftonDirector | SSaleOrdinary Shares, $0.00001 par value | −341.7K | $21.71 | −$7.42M | −98.5%5.20K after | 3 lots |
| Aug 4, 2021 (view filing) | Aug 2-4 | 2 days | Smith Christopher MChairman and CEO | SSaleOrdinary Shares, $0.00001 par value | −270.0K | $21.82 | −$5.89M | −42.4%367.4K after | 3 lots |